Search
# Popular search #
中文站
# Popular search #
Currently, we have?five recombinant insulin analogs commercialized in China including long-acting glargine injection (Basalin?), fast-acting lispro injection (Prandilin?), fast-acting aspart injection (Rapilin?), mixed protamine zinc lispro injection (25R) (Prandilin?25), aspart 30 injection (Rapilin?30), and one human insulin injection?approved in China - mixed protamine human insulin injection (30R) (Similin?30).?We?have two medical devices, namely?reusable insulin injection pen?(GanleePen),?and disposable pen needle (GanleeFine?).
The site you are about to visit is maintained by a third party who is responsible for its content.
This link is provided on the Gan & Lee website as a service to our visitors. Gan & Lee is not responsible for the privacy policy of any third-party websites. Gan & Lee encourages visitors to read the privacy policy of every website that you may visit.